Impact News +++ Glencore startet Aktienrückkaufprogramm von bis zu 1 Milliarde US-Dollar (Cash) +++ GLENCORE Aktie -3,74%

ELANCO Aktie

>ELANCO Aktienkurs

12.448 EUR +0.7% (Tradegate)

Ask: 12.448 EUR / 200 Stück

Bid: 12.374 EUR / 487 Stück

Tagesumsatz: 101 Stück

Realtime Kurs von 8 bis 22 Uhr!

ELANCO Aktie über LYNX handeln

Intraday

1 Jahr

>ELANCO Performance

1 Woche: 0%

1 Monat: +4,1%

3 Monate: +49,0%

6 Monate: +4,5%

1 Jahr: -7,5%

laufendes Jahr: +6,5%

>ELANCO Aktie

Name:

ELANCO ANIMAL HEALTH.

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US28414H1032 / A2N6BH

Symbol/ Ticker:

5EA (Frankfurt) / ELAN (NYSE)

Kürzel:

FRA:5EA, ETR:5EA, 5EA:GR, NYSE:ELAN

Index:

Webseite:

https://www.elanco.com/

Marktkapitalisierung:

5910 Mio. EUR

Umsatz:

3831.63 Mio. EUR

EBITDA:

745.57 Mio. EUR

Gewinn je Aktie:

0.562 EUR

Schulden:

3797.04 Mio. EUR

Liquide Mittel:

421.22 Mio. EUR

Umsatz-/ Gewinnwachstum:

-1% / 109.4%

KGV/ KGV lG:

18.48 / 16.31

KUV/ KBV/ PEG:

1.56 / 1.08 / 6.79

Gewinnm./ Eigenkapitalr.:

8.43% / 6.01%

Dividende je Aktie:

Dividendenrendite/ -schätzung:

- / -

Insiderhandel:

Suchwörter:

ELANCO

Letzte Datenerhebung:

07.07.25

>ELANCO Eigentümer

Aktien: 496.65 Mio. St.

f.h. Aktien: 492.86 Mio. St.

Insider Eigner: 1.03%

Instit. Eigner: 101.48%

Leerverk. Aktien: 4.91%

>ELANCO Peer Group

AKERO

BEONE ADR

BLUEPRINT MEDICINES

BRIDGEBIO

EXELIXIS

HEALTHEQUITY

INTELLIA

LIGAND

TWIST BIOSCIENCE

ULTRAGENYX

>ELANCO Chart & Kurs - NYSE

>ELANCO News

03.07.25 - 13:42	Elanco in licensing pact with Australia’s Neurizon (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

03.07.25 - 01:36	Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 (PR Newswire)
	Highlights: Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement Provides worldwide rights for Neurizon to utilise Elanco's intellectual property, providing exclusive access to an extensive package of non-clinical studies and manufacturing......

26.06.25 - 19:42	Elanco Releases 2024 Impact Report and Introduces New Framework (Accesswire)
	GREENFIELD, IN / ACCESS Newswire / June 26, 2025 / Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced the release of its 2024 Impact Report, showcasing its efforts to enhance animal ca......

26.06.25 - 19:01	Elanco Releases 2024 Impact Report and Introduces New Framework (PR Newswire)
	GREENFIELD, Ind., June 26, 2025 /PRNewswire/ -- Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced the release of its 2024 Impact Report, showcasing its efforts to enhance animal care, not just improving the lives of animals but also the people who care for them. Reflecting......

13.06.25 - 00:12	Elanco gains positive EMA opinion for Zenrelia for itching in dogs (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.06.25 - 22:18	Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU′s Committee for Veterinary Medicinal Products (CVMP) (PR Newswire)
	Company expects approval and product supply in market before the end of third quarter GREENFIELD, Ind., June 12, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) announced today that Zenrelia™ (ilunocitinib) has been granted a positive opinion by the European Medicines......

10.06.25 - 19:45	What Makes Elanco Animal Health (ELAN) a New Buy Stock (Zacks)
	Elanco Animal Health (ELAN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....

06.06.25 - 16:42	Elanco Releases New Report Highlighting the Significance of America′s Itchy Dogs and the Need for Itch Relief (Accesswire)
	The first-of-its-kind report includes results from multiple surveys revealing just how badly dogs around the country are itching for relief.Data reveals that nearly 9 in 10 dogs in the U.S. are "it......

05.06.25 - 13:48	Elanco Releases New Report Highlighting the Significance of America′s Itchy Dogs and the Need for Itch Relief (PR Newswire)
	The first-of-its-kind report includes results from multiple surveys revealing just how badly dogs around the country are itching for relief. Data reveals that nearly 9 in 10 dogs in the U.S. are "itchy dogs" according to their pet owners, having experienced symptoms of itchiness at some......

28.05.25 - 17:06	How Elanco Plans on Winning in the Pet Wellness Boom (Bloomberg)
	The animal health care company Elanco is reaffirming its second quarter and full year guidance. The company is also announcing a new CFO as the company looks to accelerate growth. Jeff Simmons, Elanco's CEO joined the C-Suite on Bloomberg's Open Interest to talk about the booming pet care market (Source: Bloomberg)...

28.05.25 - 14:15	Elanco taps Robert VanHimbergen as CFO (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

28.05.25 - 13:27	Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer (PR Newswire)
	GREENFIELD, Ind., May 28, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the appointment of Robert VanHimbergen as Executive Vice President and Chief Financial Officer, effective July 7, 2025. VanHimbergen's appointment follows an extensive and......

16.05.25 - 14:01	Elanco to Participate in the Upcoming Investor Conferences (PR Newswire)
	GREENFIELD, Ind., May 16, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced that management will participate in upcoming investor conferences. On Thursday, May 22, Jeff Simmons, president and CEO, will participate in the BNP Paribas 2nd Annual Animal......

07.05.25 - 18:57	Elanco raises 2025 innovation revenue target to $740M driven by new product launches (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.05.25 - 16:30	Compared to Estimates, Elanco Animal Health (ELAN) Q1 Earnings: A Look at Key Metrics (Zacks)
	While the top- and bottom-line numbers for Elanco Animal Health (ELAN) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....

07.05.25 - 15:01	Elanco Animal Health Incorporated (ELAN) Beats Q1 Earnings and Revenue Estimates (Zacks)
	Elanco Animal Health (ELAN) delivered earnings and revenue surprises of 19.35% and 2.17%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...

07.05.25 - 14:39	Elanco spikes after Q1 beat and guidance raise (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.05.25 - 12:32	Elanco Animal Health Reports First Quarter 2025 Results (PR Newswire)
	Accelerating Debt Paydown in 2025 First Quarter 2025 Financial Results: Revenue of $1,193 million, a decline of 1% year-over-year; 4% organic constant currency growth Reported Net Income of $67 million, Adjusted Net Income of $184 million Adjusted EBITDA of $276 million, or 23.1% of......

07.05.25 - 12:31	Elanco Non-GAAP EPS of $0.37 beats by $0.07, revenue of $1.19B beats by $20M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.05.25 - 17:42	Elanco Q1 2025 Earnings Preview (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Es geht nichts über ein ruhiges Leben, wie der Mann sagte, als er die Stelle eines Leuchtturmwärters annahm. - Charles Dickens

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram